
Analysts Viewpoint
Checking in on Collegium Pharmaceutical Inc (COLL) after recent insiders movement
Collegium Pharmaceutical Inc’s recent filing unveils that its Former Director Heffernan Michael Thomas acquired Company’s shares for reported $0.33 million